YourLawyer.com® 1-800-LAW-INFO (1-800-529-4636)
Ethex
ETHEX Generic Drug Recall Lawyers
Keywords: Ethex | Lawyer | Recall | Lawsuit | Overdose
In November 2008, ETHEX Corporation recalled various lots and sizes of Propafenone HCl Tablets, Isosorbide Mononitrate Extended Release Tablets, Morphine Sulfate Extended Release Tablets, Morphine Sulfate Immediate Release Tablets and Dextroamphetamine Sulfate Tablets. ETHEX initiated the recall because of the potential that some of the tablets were oversized. Oversized tablets may contain more than the intended levels of the active drug ingredient, which could result in an overdose.
According to the Food & Drug Administration (FDA) overdoses of Propafenone HCl, Isosorbide Mononitrate, Morphine sulfate and Dextroamphetamine Sulfate can have serious or life-threatening consequences. Excessive exposure to Propafenone HCl can cause arrhythmias (irregular heartbeat) and low blood pressure. In the case of Isosorbide Mononitrate, these consequences can include fainting and low blood pressure. The consequences of Morphine Sulfate overdose can include respiratory depression (difficulty or lack of breathing) and low blood pressure. An overdose of Dextroamphetamine Sulfate can caused rapid heart rate and high blood pressure.
If you or someone you know experienced an overdose because of defective Propafenone HCl Tablets, Isosorbide Mononitrate Extended Release Tablets, Morphine Sulfate Extended Release Tablets, Morphine Sulfate Immediate Release Tablets and Dextroamphetamine Sulfate Tablets recalled by ETHEX Corporation, you may be entitled to compensation. Please contact one of our ETHEX generic drug recall lawyers right away to protect your legal rights.
Medications Included in ETHEX Generic Drug Recall
According to the FDA, the November 2008 ETHEX recall included the following generic medications:
Propafenone HCl Tablets, 150 mg: The 150 mg Propafenone Hydrochloride Tablets is a white, scored round film coated tablet with "ETH" on one side and "331" with a bisect on the reverse. Lots: 73761, 78184, 79373, 81240, 81241, 81242, 83470, 84357, 90525, and 90526 with expiration dates ranging from 3/2009 to 3/2011
Propafenone HCl Tablets, 225 mg: The 225 mg Propafenone Hydrochloride Tablets is a white, scored round film coated tablet with "ETH" on one side and "332" with a bisect on the reverse. Lots: 71720, 74831, 76014-15, 81243-45, 89731, 90527-29, and 90657 with expiration dates ranging from 3/2009 to 2/2011
Propafenone HCl Tablets, 300 mg: The 300 mg Propafenone Hydrochloride Tablets is a white, scored round film coated tablet with "ETH" on one side and "333" with a bisect on the reverse. Lots: 72834, 76016-18, 81246, 89092, 89732, 90530, 90532, and 91641-42 with expiration dates ranging from 6/2009 to 3/2011
Isosorbide Mononitrate Extended Release Tablets, 30 mg: The 30 mg Isosorbide Mononitrate Extended Release Tablet is an oval, reddish-pink, film-coated tablet with a debossed "E" bisecting "30" on one side and bisect on the other side. Lots: 62355, 66423, and 68102 with expiration dates ranging from 11/2008 to 8/2009
Isosorbide Mononitrate Extended Release Tablets, 60 mg: The 60 mg Isosorbide Mononitrate Extended Release Tablet is an oval, yellow film-coated tablet with a debossed "E" bisect "60" on one side and bisect on the other side. Lots: 63466, 66034, 67351, and 67354 with expiration dates ranging from 12/2008 to 11/2009
Morphine Sulfate Extended Release Tablets, 15 mg: The 15 mg Morphine Sulfate Extended Release Tablet is a green oval tablet with "15" on one side and an "E" on the reverse. Lots: 81175, 82514-16, 89660, 89664, 89667, 90249-51, and 91687 with expiration dates ranging from 12/2008 to 2/2010
Morphine Sulfate Immediate Release Tablets, 15 mg: The 15 mg Morphine Sulfate Immediate Release Tablet is a round brown tablet with a "15" on one side and an "ETH" on the reverse. Lots: 77852-54, 81746, 82519-20, 84113, and 90276-78 with expiration dates ranging from 9/2009 to 1/2011
Morphine Sulfate Immediate Release Tablets, 30 mg: The 30 mg Morphine Sulfate Immediate Release Tablet is a capsule shaped brown tablet with "30" on one side and an "ETHEX" on the reverse. Lots: 75093, 77855-57, 82297, 82521-22, 87239, 88925, and 90288-98 with expiration dates ranging from 8/2009 to 3/2011
Dextroamphetamine Sulfate Tablets, 10 mg: The 10 mg Dextroamphetamine Sulfate Tablet is a round, flat-face, bevel edge, orange mottled tablet debossed "ETHEX" and "312" on one side and double-scored on the other side. Lots: 73934, 75892, 77945, 81137, 86320 with expiration dates ranging from 6/2009 to 5/2011
All of the generic drugs involved in this latest recall were shipped prior to May 22, 2008. Consumers who have questions regarding the ETHEX generic drug recall should call their physicians or pharmacist. They may also contact ETHEX Customer Service at 1-800-748-1472. Consumers who experience any adverse reactions to these drugs should contact their physician and/or healthcare provider immediately.
Other ETHEX Generic Drug Recalls
ETHEX has had previous problems with oversized medications. In June 2008, ETHEX recalled several lots of 60 mg and 30 mg morphine extended release tablets that may have been oversized. The recall was issued after ETHEX received a report of one oversized morphine tablet in one manufacturing lot. ETHEX characterized that recall as a precaution, and said that no additional oversized tablets had been identified in the affected lots.
Then in October 2008, ETHEX recalled three lots of potentially oversized Dextroamphetamine Sulfate 5 mg tablets. ETHEX issued the recall after it discovered and removed a small number of oversized tablets in lots the company had not yet distributed. However, because there are multiple companies in the U.S. producing and marketing generic versions of Dextroamphetamine Sulfate 5 mg tablets, patients and caregivers were urged to check their prescriptions to determine the source of their tablets.
Legal Help for victims of Defective ETHEX Generic Drugs
If you or a loved one have been injured as a result of an oversized ETHEX generic drug, you have valuable legal rights. Please fill out our online form, or call 1-800 LAW INFO (1-800-529-4636) to discuss your case with an experienced ETHEX generic drug recall lawyer.
EthexRSS Feed
FDA Takes Action Against KV Pharmaceuticals
Mar 3, 2009 | Parker Waichman Alonso LLP
The U.S. Food and Drug Administration (FDA) just announced that a Consent Decree of permanent injunction was filed yesterday enjoining KV Pharmaceutical Company, its subsidiaries ETHEX Corporation and Ther-Rx Corporation, and its principal officers, from making and distributing adulterated and unapproved drugs.This is the most recent in an extensive series of incidents regarding KV Pharmaceuticals and its subsidiaries. Early last month, ETHEX expanded a prior generic drug recall. ...
ETHEX Generic Drug Recall Expanded
Feb 5, 2009 | Parker Waichman Alonso LLP
ETHEX Corp. has expanded an earlier generic drug recall. Like other ETHEX recalls from the past several months, this expanded drug recalls was necessary because of manufacturing problems at KV Pharmaceuticals, the parent company of ETHEX.The expanded recall includes:Morphine Sulfate Extended-Release Tablets 15mg, 30mg & 60mg (All Strengths)Morphine Sulfate Immediate-Release Tablets 15mg & 30 mg (All Strengths)Dextroamphetamine Sulfate Tablets 5mg & 10mg (All...
ETHEX Recalls Infant Vitamins, Iron Supplements
Feb 4, 2009 | Parker Waichman Alonso LLP
ETHEX Corp. has issued another big drug recall. This time ETHEX, a unit of KV Pharmaceuticals, is recalling several varieties of prescription infant vitamins and prescription iron supplement products that may have been manufactured under conditions that did not sufficiently comply with the Food & Drug Administration's (FDA) current Good Manufacturing Practice (cGMP).Last month, KV Pharmaceuticals suspended manufacturing and shipping of all of its products, including those made...
ETHEX Issues Massive Recall of Generic Drugs
Jan 29, 2009 | Parker Waichman Alonso LLP
ETHEX Corp. is recalling scores of generic drugs that might be defective. The recall is part of a larger action taken by KV Pharmaceuticals - the parent of ETHEX Corp. - which we reported on earlier this week. According to an ETHEX press release, the massive recall is necessary because the medications may have been manufactured under conditions that did not sufficiently comply with current Good Manufacturing Practices. Some of the medications have had specific lots...
ETHEX Recalls More Oversized Drugs
Dec 24, 2008 | Parker Waichman Alonso LLP
ETHEX Corp. has announced another recall of oversized tablets. This time, the company is recalling a single lot of Hydromorphone HCl 2 mg tablets. According to the Food & Drug Administration (FDA), Hydromorphone is a drug used for pain management and is packaged under the ETHEX label in 100-count bottles.The ETHEX Hydromorphone recall involves Lot #90219, Exp: 03/2010; NDC #58177-0620-04. ETHEX has initiated recall notifications to wholesalers and retailers nationwide who...
Defective Drugs
News Feeds
WE ALSO OFFER OUR FIRM NEWS AS RSS/XML FEEDS.
LEARN MORE ABOUT RSS